There are four main types of lupus: systemic lupus erythematosus (SLE), cutaneous lupus (skin lupus), drug-induced lupus, and neonatal lupus. Systemic lupus accounts for about 70% of all cases, while cutaneous and drug-induced lupus each represent roughly 10%. The Lupus Foundation of America estimates that 1.5 million Americans have some form of the disease.
Each type affects the body differently, ranges from mild to serious, and requires its own approach to treatment. Here’s what distinguishes them.
Systemic Lupus Erythematosus (SLE)
SLE is the type most people mean when they say “lupus.” It’s a chronic autoimmune disease in which the immune system attacks healthy tissue throughout the body, potentially affecting the skin, joints, kidneys, heart, lungs, brain, blood cells, and digestive system. The CDC estimates about 204,000 people in the United States have SLE specifically.
Symptoms vary widely from person to person. Joint pain and swelling are among the most common early signs, along with fatigue, fevers, and a butterfly-shaped rash across the cheeks and nose. Because lupus can mimic so many other conditions, getting a diagnosis often takes time. Doctors typically look for a positive antinuclear antibody (ANA) blood test as a starting point, then evaluate a combination of symptoms and lab results to confirm the diagnosis.
Most people with SLE take hydroxychloroquine, an antimalarial drug that helps keep symptoms in check with relatively few side effects. Many stay on it long-term. When lupus affects organs like the kidneys, heart, or brain, doctors may add stronger medications that suppress the immune system. Three biologic drugs are also now approved specifically for lupus, offering additional options for people whose disease doesn’t respond well to standard treatment.
Cutaneous Lupus (Skin Lupus)
Cutaneous lupus is limited to the skin and comes in three subtypes: chronic cutaneous lupus (also called discoid lupus), subacute cutaneous lupus, and tumid lupus.
Discoid lupus is the most recognizable form. It produces thick, scaly patches that typically appear on the face, neck, and scalp. Over time, these patches expand at the edges and heal inward, leaving behind discolored skin and sunken scars. On the scalp, discoid lupus can cause permanent hair loss. It’s more common in smokers and African Americans.
Subacute cutaneous lupus tends to cause red, ring-shaped lesions on sun-exposed areas. It’s strongly linked to sun sensitivity, and flares often follow UV exposure. Tumid lupus, the least common subtype, produces raised, smooth, reddish-purple patches without the scarring seen in discoid lupus.
Treatment for skin lupus often starts with topical steroid creams or gels, which manage symptoms with fewer side effects than oral medications. Hydroxychloroquine is also commonly prescribed. An important thing to know: about 5% or more of people with cutaneous lupus eventually develop systemic lupus, so ongoing monitoring matters even when the disease appears confined to the skin.
Drug-Induced Lupus
Drug-induced lupus looks a lot like SLE, with joint pain, muscle aches, and inflammation around the lungs being the most common symptoms. The key difference is the cause: it’s triggered by certain prescription medications, and it typically resolves within days to weeks after stopping the drug.
The medications most frequently linked to drug-induced lupus include hydralazine (a blood pressure drug), procainamide (a heart rhythm medication), isoniazid (used for tuberculosis), minocycline (an antibiotic often prescribed for acne), and TNF-alpha inhibitors used for rheumatoid arthritis and related conditions. Less commonly, anti-seizure medications, certain cancer immunotherapy drugs, and even levamisole (a contaminant sometimes found in cocaine) can trigger it.
Drug-induced lupus accounts for roughly 10% of all lupus cases. Unlike SLE, it rarely affects the kidneys or brain, and it doesn’t become a lifelong condition. Once the triggering medication is identified and discontinued, most people recover fully without needing long-term treatment.
Neonatal Lupus
Neonatal lupus is rare and affects newborns. It isn’t caused by the baby having lupus itself. Instead, it happens when certain antibodies from the mother cross the placenta during pregnancy. The antibodies responsible are called anti-Ro and anti-La (sometimes referred to as anti-SSA and anti-SSB). A mother can carry these antibodies whether or not she has been diagnosed with lupus herself.
The most visible sign is a skin rash at birth or within the first few months of life: round, ring-shaped marks with reddish borders and clear centers. This rash is temporary and harmless. Some babies also develop low blood cell counts or elevated liver enzymes, which typically resolve on their own.
The most serious potential complication is congenital heart block, where the antibodies interfere with the electrical signals that keep the baby’s heart beating in rhythm. Complete heart block can prevent the heart from pumping enough blood and may require a pacemaker. Pregnant women known to carry anti-Ro or anti-La antibodies are typically monitored closely so heart problems can be detected early.
How the Types Overlap
These four categories aren’t always neatly separated. Someone with cutaneous lupus may later develop systemic involvement. A person with SLE almost always has skin symptoms at some point. And drug-induced lupus can be tricky to distinguish from SLE until the medication is stopped and symptoms clear.
The unifying feature across all types is an immune system that’s reacting to the body’s own tissues. What varies is which tissues are targeted, what triggers the reaction, and how long it lasts. Understanding which type you’re dealing with shapes everything from treatment choices to long-term outlook.